Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery

Circulation

Volumn 96, Issue 4, 1997, Pages 1299-1304

  Matsuno, Hiroyuki ^a   Kozawa, Osamu ^b   Niwa, Masayuki ^b   Uematsu, Toshihiko ^b  

^a GIFU UNIVERSITY   (Japan)

^b NONE

Author keywords

Arteries; Glycoproteins; Platelets; Stenosis; Von Willebrand factor

Indexed keywords

ADENOSINE DIPHOSPHATE; AURINTRICARBOXYLIC ACID; BOTROCETIN; BROXURIDINE; DNA; GLYCOPROTEIN IB; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; HAMSTER; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA; THROMBOGENESIS;

EID: 0030761798     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.4.1299     Document Type: Article

References (25)

1. Kalafatis M, Takahashi Y, Girma JP, Meyer D. Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly 911 and Glu 1,365. Blood. 1987; 70:1577-1583.
2. Fauvel-Lafeve F, Legrand YJ. Binding of plasma von Willebrand factor by arterial microfibrils. Thromb Haemost. 1990;64:145-149.
3. de Groot PG, Ottenhof-Rovers M, van Mourik JA, Sixma JJ. Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen. J Clin Invest. 1988;82:65-73.
4. Girma JP, Kalafatis M, Pietu G, Lavergne JM, Chopek MW, Edgington TS, Meyer D. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. Blood. 1986;67:1356-1366.
5. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood. 1983;61:99-110.
6. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo H, Kawai Y, Watanabe K, Itagaki I. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 1991;87:1234-1240.
7. 2, an anti-guinea pig platelet glycoprotein Ib monoclonal antibody. Arterioscler Thromb. 1991;11:1231-1236.
8. Phillips MD, Moake JL, Nolasco L, Turner N. Aurintricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. Blood. 1988;72:1898-1903.
9. Strony J, Phillips M, Brands D, Moake J, Adelman B. Aurintricarboxylic acid in a canine model of coronary artery thrombosis. Circulation. 1990;81:1106-1114.
10. Gold HK, Gimple LW, Yasuda T, Leinbach RC, Werner W, Holt R, Jordan R, Berger H, Collen D, Coller BS. Pharmacodynamic study of F(ab′), fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotcin IIb/IIIa in patients with unstable angina pectoris. J Clin Invest. 1990;86:651-659.
11. Coller BS, Seligsohn U, West SM, Scudder LE, Norton KJ. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIa and αvβ3 integrins in platelet protein trafficking. Blood. 1991;78:2603-2610.
12. Matsuno H, Stassen JM, Vermylen J, Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
13. Kawasaki T, Kaku S, Kohinata T, Sakai Y, Taniuchi Y, Kawamura K, Yano S, Takenaka T, Fujimura Y. Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo. Am J Hematol. 1994;47:6-15.
14. Weinstein M, Vosburgh E, Phillips M, Turner N, Chute-Rose L, Moake J. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib: comparison with other polyanionic and polyaromatic polymers. Blood. 1991;78:2291-2298.
15. Haugwitz R. New anti-HIV compounds belonging to aurintricarboxylic acid. US Patent 7431568, 1989.
16. Matsuno H, Stassen JM, Hoylaerts MF, Vermylen J, Deckmyn H. Fast and reproducible vascular neointima formation in the hamster carotid artery: effects of trapidil and captopril. Thromb Haemost. 1995;74:1591-1596.
17. Matsuno H, Uematsu T, Umemura K, Takiguchi Y, Wada K, Nakashima M. Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator. Br J Pharmacol. 1992;106:533-538.
18. Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest. 1992; 90:2044-2049.
19. Matsuno H, Stassen JM, Lieve M, Vermylen J, Hoylaerts MF. Neointima formation in injured hamster carotid artery is effectively prevented by the combination G4120 and quinapril. Thromb Haemost. 1996;76:263-269.
20. Matsuno H, Uematsu T, Nagashima S, Nakashima M. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Methods. 1991;25:303-317.
21. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1132.
22. Kang SS, Gosselin C, Ren D, Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions. Surgery. 1995;118:280-287.
23. Azzam K, Cisse-Thiam M, Drouet L. The antithrombotic effect of aurintricarboxylic acid in the guinea pig is not solely due to its interaction with the vWF-GPIb axis. Thromb Haemost 1996;75: 203-210.
24. Kaida T, Matsuno H, Niwa M, Kozawa O, Uematsu T. Effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Thromb Haemost. 1997;77:562-567.
25. Benezra M, Ben-Sasson SA, Regan J, Chang M, Bar-Shavit R, Vlodavsky I. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds. Arterioscler Thromb. 1994;14:1992-1999.